Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 5.32Sales per Share
VS
Market
Sector
Industry
History
$ 57.77Close
$ 7.36 - $ 60.55 52-Week Range
Ticker Information
Ticker
NKTRCompany Name
NEKTAR THERAPEUTICSSector
HealthcareIndustry
BiotechnologyExchange
NASDAQNEKTAR THERAPEUTICS - Sales per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NKTR - SPS Historical data
| Date | Revenues | Share Factor | Weighted Average Shares | Sales per Share |
|---|---|---|---|---|
| 6/30/2025 | $ 74.93M | 1 | 14.09M | $ 5.32 |
| 3/31/2025 | $ 87.25M | 1 | 14.06M | $ 6.2 |
| 12/31/2024 | $ 98.43M | 1 | 13.71M | $ 7.18 |
| 9/30/2024 | $ 93.14M | 1 | 13.95M | $ 6.68 |
| 6/30/2024 | $ 93.16M | 1 | 13.92M | $ 6.69 |
| 3/31/2024 | $ 90.17M | 1 | 12.98M | $ 6.94 |
| 12/31/2023 | $ 90.12M | 1 | 12.67M | $ 7.11 |
| 9/30/2023 | $ 88.26M | 1 | 12.69M | $ 6.95 |
| 6/30/2023 | $ 87.74M | 1 | 12.64M | $ 6.94 |
| 3/31/2023 | $ 88.83M | 1 | 12.59M | $ 7.05 |
Key Performance Insights, Last 5 Years
- NEKTAR THERAPEUTICS's latest trailing twelve months (TTM) SPS stands at $ 13.68.
- Over the past 5 years, NEKTAR THERAPEUTICS's average SPS has been $ 8.01.
- The median SPS for NEKTAR THERAPEUTICS during this period was $ 7.28
- NEKTAR THERAPEUTICS reached its highest SPS over the past 5 years at $ 13.68.
- The lowest SPS recorded by NEKTAR THERAPEUTICS in the same timeframe $ 5.32
NEKTAR THERAPEUTICS's SPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SPS Benchmarks
Similar metrics to SPS:
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Sales per Share
[Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].Revenues / (Shares WA * Share Factor)
(=) SPS SPS for NEKTAR THERAPEUTICS is calculated as follows: Revenues [ $ 163.31M ] / (Shares WA [ 11.94M ] * Share Factor [ 1 ])
(=) SPS [ $ 13.68 ] NKTR - Sales per Share, Last 5 years
$ 5.32
Minimum
Jun 30, 2025
$ 13.68
Maximum
Sep 30, 2020
$ 8.01
Average
$ 7.28
Median
SPS Benchmark AnalysisMarket
The chart above depicts the distribution of SPS for companies in the Total Stock Market. The average SPS of the companies is $ 11.53 with a standard deviation of $ 13.59.
The following table provides additional summary stats:
SPS in the Market:
| filtered constituents | 3.64K |
|---|---|
| min | $ -18.02 |
| max | $ 54.75 |
| average | $ 11.53 |
| median | $ 5.88 |
| std | $ 13.59 |